Overview
Venture investment platform acquired by Goldman Sachs in January 2026 and integrated into its External Investing Group. Strategies span seed funds, direct investments, secondaries and technology buyouts. Healthcare investments have included Hinge Health, Curebase, Meru Health and Guardant Health.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.